Abstract:Objective To explore if vasculogenic mimicry (VM) exists in human primary gallbladder carcinomas and evaluate the correlation between the VM and expression of vascular epithelial growth factor (VEGF) in gallbladder carcinomas and its significance. MethodsSeventy-four carcinomas, 10 adenomas and 10 chronic inflammatory lesions of the gallbladder underwent operation and confirmed histopathologically were studied. Clinical-pathological data and survival of each patient with gallbladder carcinoma were recorded and followed-up. VM in human gallbladder carcinomas was observed under light microscope by HE staining, CD31 and PAS staining; the expression of VEGF proteins in each paraffin section of each patient in vivo was determined by Envision method of immunohistochemistry; the correlation among the VM, VEGF expression and their clinical significance in the patients with gallbladder carcinomas were analyzed and compared by Kaplan-Meier actuarial survival curves and Cox multiple factors. Results①13.5% (10/74) of human gallbladder carcinomas were found to contain VM, namely intratumoral, tumor cell-lined extracellular matrix (ECM)-rich, PAS-positive and vasculogenic-like network patterns. VM was associated with histological type (χ2=10.241,P=0.017), hepatic metastasis (χ2=4.238,P=0.042) and poor overall survival (χ2=5.722 1,P=0.016). ②Expression of VEGF was increased significantly in carcinomas with or without VM than adenomas and inflammatory lesions of the gallbladder (P<0.000 1) in vivo; VEGF expression in the gallbladder carcinomas without VM was increased significantly than that with VM (P=0.018 2). ③There is positive correlation between expression of VEGF and the gallbladder carcinomas without VM in the cases of Nevin stage (P=0.003 5), invasion depth (P=0.005 9), liver metastases (P=0.037 3) and lymph node metastases (P=0.000 1), the same correlation was only observed between expression of VEGF and the gallbladder carcinomas with VM in the cases of liver metastases (P=0.032 3). When being compared the non-VM gallbladder carcinomas with the VM gallbladder carcinomas, expression of VEGF in the same conditions of Nevin stage (S3～S5, P=0.049 0) was higher significantly in the gallbladder carcinomas without VM than those with VM. ④The non-VM group underwent operation with positive expression of VEGF had longer 5-year survival than the VM group (P=0.007 2), furthermore, the non-VM group underwent operation with negative expression of VEGF had longer 5-year survival than the positive expression group (P=0.031). Also, VM, as invasive depth, lymph node metastasis, hepatic metastasis and operational method, is an independent, risk prognostic factor for patients with gallbladder carcinoma by Cox multiple factor analysis. ConclusionsVM, as a new blood supply for the growth of gallbladder carcinomas, is found to exist in the patients with gallbladder carcinomas. Increased expression of VEGF and its negative correlation with VM were observed in the gallbladder carcinomas. It is showed that VM is an independent risk prognostic factor in patients with gallbladder carcinoma, and VEGF is an important clinical marker for evaluation of Nevin stage, invasion depth, lymph node or liver metastases and prognosis in patients with gallbladder carcinoma; VM and VEGF are especially of important markers for estimating of prognosis in the gallbladder carcinoma patients.

A Pilot Histomorphology and Hemodynamic of Vasculogenic Mimicry in Gallbladder Carcinomas in Vivo and in Vitro

Insight into diagnosis and treatment of gallbladder cancer from vasculogenic mimicry:a new blood supply for gallbladder cancer

Vasculogenic Mimicry in Human Primary Gallbladder Carcinoma and Clinical Significance Thereof

A new blood supply for human primary gallbladder carcinomas:vasculogenic mimicry,and its correlation with VEGF and significance

Vasculogenic mimicry,HIF-1α and VEGF expression in gallbladder carcinoma:association with clinical outcomes and prognostic implications

Contribution Of The Pi3k/Mmps/Ln-5 Gamma 2 And Epha2/Fak/Paxillin Signaling Pathways To Tumor Growth And Vasculogenic Mimicry Of Gallbladder Carcinomas

[Vasculogenic Mimicry in the Bi-Directional Differentiation Malignant Tumors of Digestive Tract].

A Pilot Study of Vasculogenic Mimicry Immunohistochemical Expression in Intraocular Melanoma Model

Overexpression of HIF-1α in Primary Gallbladder Carcinoma and Its Relation to Vasculogenic Mimicry and Unfavourable Prognosis

Vasculogenic Mimicry: a New Prognostic Sign of Gastric Adenocarcinoma.

Role and Mechanism of Vasculogenic Mimicry in Gastrointestinal Stromal Tumors

[A Study on Vasculogenic Mimicry in Hepatocellular Carcinoma].

Vasculogenic Mimicry Persists During Glioblastoma Xenograft Growth

Vasculogenic Mimicry in Subcutaneous Xenograft Glioma Model of Mice

[Vasculogenic Mimicry--potential Target for Tumor Therapy].

Significance of Vasculogenic Mimicry Formation in Gastric Carcinoma

Expression of Vimentin and Oct-4 in Gallbladder Adenocarcinoma and Their Relationship with Vasculogenic Mimicry and Their Clinical Significance.

Vasculogenic Mimicry and Tumor Metastasis.

Vasculogenic Mimicry Assay of Glioma Stem Cell in Vitro

Clinical Significance of Vasculogenic Mimicry in Human Gliomas

The Morphologic Observation of Vasculogenic Mimicry in Melanoma